Editorial: Epigenetic insights into diagnostic and therapeutic applications

• Elisabetta Fratta,
• Carmen Jerónimo,
• Antionette S. Perry,
• Samantha G. Pattenden

Affiliations

Elisabetta Fratta

Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy

Carmen Jerónimo

Cancer Biology & Epigenetics Group, IPO Porto Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) and Department of Pathology and Molecular Immunology, ICBAS – School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal

Antionette S. Perry

Cancer Biology and Therapeutics Laboratory, University College Dublin (UCD) Conway Institute of Biomolecular and Biomedical Research and University College Dublin (UCD) School of Biology and Environmental Science, University College Dublin, Dublin, Ireland

Samantha G. Pattenden

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States